Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2026-01-22 @ 12:29 PM
Study NCT ID:
NCT03638167
Status:
COMPLETED
Last Update Posted:
2025-12-17
First Post:
2018-08-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors
Sponsor:
Seattle Children's Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-19
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-12-22
Completion Date Type:
ACTUAL
First Submit Date:
2018-08-15
First Submit QC Date:
None
Study First Post Date:
2018-08-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-09
Last Update Post Date:
2025-12-17
Last Update Post Date Type:
ESTIMATED